Intellipharmaceutics International Inc. (IPCI)

[AngeloFoca]

Updated Spread Sheet - to Dec 8, 2017



I'm quite happy with $5,980,000 for 4th Quarter Seroquel Sales - going forward, that is approximately $24 Million, at least, in sales for the first year - not bad I think.

What I'm not sure I'll be happy with is IPCI's portion of those sales... if less than $2.4 million for 4th quarter, then I will be very unhappy with the royalty percentage they negotiated.

I can understand the low %age on Focalin since that was financed by PAR but if they are not getting 40% royalties on a product that was brought all the way through FDA approval on IPCI's dime... then they got F$%&^#.

I agree with Tilator... selling generics is not the same as selling NDA drugs.

I would have rather they did a 10 million share offering when their stock was above $3, and raised $30 million... that would have been more than enough to get the ball rolling and develop relationships with the few major distributors... they could have sold the generics for 30% to 40% less than everybody else and still would have made much more than if not getting 40% in royalties.

We'll see what is what at next earnings, mid February???

p.s. - thanxs for the #s fred... much easier to get a feeling for what-is-what when organized into a chart.